Journal
Blood Advances
Publication Date
3-11-2025
Volume
9
Issue
5
First Page
1040
Last Page
1048
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2024014374
Rights and Permissions
Pidala J, Kim J, Kalos D, Cutler C, DeFilipp Z, Flowers MED, Hamilton BK, Chin KK, Rotta M, El Jurdi N, Hamadani M, Ahmed G, Kitko C, Ponce D, Sung A, Tang H, Farhadfar N, Nemecek E, Pusic I, Qayed M, Rangarajan H, Hogan W, Etra A, Jaglowski S. Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis. Blood Adv. 2025 Mar 11;9(5):1040-1048. doi: 10.1182/bloodadvances.2024014374. © 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Pidala, Joseph; Pusic, Iskra; and et al., "Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: A multicenter real-world analysis." Blood Advances. 9, 5. 1040 - 1048. (2025).
https://digitalcommons.wustl.edu/oa_4/4899
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
